top of page
David Kandzari, MD

David Kandzari, MD, is the Director of Interventional Cardiology and Chief Scientific Officer at the Piedmont Heart Institute in Atlanta, Georgia. Dr. Kandzari has held appointments as the Chief Medical Officer for the Cordis Corporation (Johnson & Johnson) and as a Medical Officer for the US Food and Drug Administrator (FDA) As a regulatory expert, Dr. Kandzari is a Committee Member for the FDA’s Circulatory Systems Devices Panel. He is a renowned clinical trial investigator and has held national and international leadership roles in clinical trials surrounding cardiovascular disease. Dr. Kandzari is a graduate of Duke University, where he also completed his cardiology fellowship. Dr. Kandzari completed his residency and internship at the John Hopkins University School of Medicine.

bottom of page